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Summary 
 
The proapoptotic protein Bid is phosphorylated by ATM after DNA damage and induces S-phase 
arrest by a mechanism that remains to be elucidated. Here we show that in mammalian cells, Bid 
is associated with Mre11, a subunit of the Mre11-Rad50-Nbs1 (MRN) complex. We demonstrate 
that Bid activation is abrogated in Mre11 and Nbs1 deficient primary mouse fibroblasts and cells 
from patients with ataxia talangiectasia-like disorder. Bid depletion by RNA interference 
inhibited the S-phase checkpoint activation and G2/M arrest after genotoxic insult, but had no 
effect on MRN complex formation. Our results explain the mechanism of Bid phosphorylation 
by ATM in response to DNA damage and suggest that Bid functions as a link between the MRN 
complex and S-phase regulatory proteins. 
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Introduction 
 
The activation of cell cycle checkpoints is apparently highly coordinated, but it remains a 
challenge to identify and characterize the molecular mechanisms that decode and respond to the 
competing signals controlling cell cycle progression, DNA repair and apoptosis. In response to 
DNA insults eukaryotic cells activate the two proximal checkpoint signaling kinases, ATM and 
ATR, which results in cell cycle progression delay until a decision on cell fate is determined. The 
DNA synthesis (S) phase is the genetically most vulnerable cell cycle stage and is protected by 
an intra-S phase checkpoint 1, 2. The activation of intra-S phase checkpoint in response to DNA 
damage and replication block depends on the combined actions of ATM and ATR and requires 
an intact MRN (Mre11-Rad50-Nbs1) complex 3, 4. The MRN complex is thought to act in both 
DNA repair and S-phase checkpoint and Mre11 and Nbs1 deficient mouse primary fibroblasts 
(MEFs) are unable to activate S-phase arrest after DNA damage 5-10.  
 
The intra-S phase checkpoint mainly serves to delay DNA replication by suppressing the firing 
of late origins and eventually to prevent mitotic entry when DNA damage is non-repairable. In 
contrast to G1 and G2 checkpoints, the intra-S phase checkpoint provides only a delay but not a 
permanent cell cycle arrest and serves to facilitate the repair process. Consequently, the S-phase 
checkpoint main role is to coordinate the cellular response to DNA damage with the ongoing 
DNA synthesis.  
 
Recently, a potential link between the processes of DNA repair and apoptosis has been suggested 
by Zinkel et al. (2005) and Kamer et al. (2005), demonstrating that the well-known pro-apoptotic 
factor Bid takes part in both the S-phase checkpoint activation and protection of genomic 
integrity after DNA double-strand breaks (DSBs) induction 11, 12. The molecular mechanism by 
which ATM induces Bid phosphorylation is largely unknown, but three properties of Bid 
involvement in DNA damage response are very intriguing. First, Bid phosphorylation in 
response to DNA double strand breaks induction depends exclusively on ATM kinase; second, 
Bid activation is not directly involved in apoptosis induction after DNA damage; and third, Bid 
phosphorylation is impaired in Nbs1 mutant mice that exhibit a severe defect in DSB response 7. 
Thus, Bid nuclear presence and activation in response to genotoxic stress might be dependent on 
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the recognition of DNA lesions by DNA damage sensor complexes and serve to link the repair 
centers with cell cycle checkpoints. Here, we show that Bid activation after DNA damage is 
mediated by Bid association with MRN complex trough the Mre11 subunit, which allows Bid 
phosporylation by ATM and mainly function to induce an intra-S phase checkpoint arrest. 
 
Results and Discussion 
 
Bid coimmunoprecipitates with Mre11 subunit of Mre11-Rad50-Nbs1 (MRN) DNA damage 
sensory complex 
 
Bid phosphorilation in mammalian cells is triggered in response to DNA double-strand breaks 
(DSBs) by ATM protein kinase. We reasoned that Bid phosphorilation might depend on DSBs 
recognition by protein complexes that act as sensors and stimulate ATM activity. Previous 
studies have shown that Bid is expressed at low levels in the nucleus 11-13. To optimize 
expression of Bid in the nucleus and increase the probability of detecting Bid interacting partners 
we transiently transfected HeLa cells with a recombinant highly purified Bid protein labeled with 
the biotin-linked photocrosslinkable reagents Sulfo-SBED on lysines and Mts-Atf on cysteins 
(Pierce) and purified Bid and associated proteins were purified by streptavidine magnetic beads 
(Figure 1A; Supplementary Figure 1). Bid expression in the nucleus of transfected HeLa cells 
was confirmed by immunoblot using a Bid specific polyclonal antibody (Figure 1B). Cells 
transfected with Bid preparations were cultured for 8 h before being treated with 20 nM 
etoposide to induce DNA damage. Crosslinkers activation, which can form covalent linkage with 
most amino residues of interacting proteins, was induced by UV light 4 h after etoposide 
treatment. Nuclear extracts were prepared and following streptavidine purification, the isolated 
polypeptides were separated by SDS-PAGE and visualized by Colloidal Blue staining (Figure 1 
C and Supplementary Figure 2) The excised bands were subjected to nanoflow LC ESI tandem 
mass spectroscopic (LC-MS/MS) analysis. This proteomic approach revealed that major Bid-
associated polypeptides were Mre11, Rad50, Ku70/80 heterodimer, DNA-PK, Fen1 flap 
endonuclease, MCM5 and casein kinase 2 (Figure 1C and Supplementary Table 1). Mre11 and 
Rad50 are subunits of the Mre11-Rad50-Nbs1 (MRN) complex and essential components of the 
DNA damage recognition apparatus 4, 14, while Ku70/80 and DNA-PK are core components of 
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non-homologous end joining complex 15, 16. Bid also associated with Fen1 flap endonuclease, 
which is required for DNA replication and repair, as well as the microchromosome maintenance 
complex protein MCM5 and casein kinase 2 17-19.  
 
To confirm the association with Bid we preformed immunoprecipitations with Bid antiserum 
followed by western blotting with a battery of antibodies that recognized Mre11, Nbs1, Rad50, 
Ku70, Ku80 and DNA-PK. Figures 1D and E shows that Ku70 and Mre11 were 
immunoprecipitated from HeLa cells with an Bid antibody, In contrast, Ku80, Rad50, Nbs1 and 
DNA-PK were not present in the Bid immunoprecipitates  (Figure 1D and E and data not shown). 
These results suggested that Bid-Mre11 and Bid-Ku70 associations are specific and might play a 
role in the DNA damage response. 
 
Bid phosphorilation by ATM requires an intact MRN complex 
  
The association of Bid with Ku70 and Mre11 raised the possibility that Bid phosphorilation by 
ATM in response to DNA damage induction might depend on the Ku70 and Mre11 expression. 
To address this issue, we evaluated a series of mouse primary fibroblasts (MEFs) deficient for 
the DNA repair genes Ku70, Mre11 and Nbs1 and cells from patients with ataxia telangiectasia-
like (ATLD) disorder that express mutant forms of Mre11 protein 6. In the absence of intact 
Mre11 and Nbs1, Bid phosphorilation at serines 61/64 in response to etoposide treatment was 
almost completely abolished (Figure 2A). In contrast, Bid phosphorilation in response to DNA 
damage was not affected in MEFs deficient for Ku70 indicating that Bid association with Ku70 
has a minimal role in Bid activation (Figure 2B).  We also tested whether Bid phosphorilation is 
inhibited in ATLD cells that exhibit severe chromosomal instability and checkpoint defects as a 
result of hypomorphic mutations in Mre11 gene 6, 8. Primary human fibroblasts and ATLD cells 
were treated with etoposide to induce DNA damage and Bid phosphorilation at serines 61/64 was 
analyzed by Western blotting in nuclear and cytosolic protein extracts. Figure 2C shows that Bid 
phosphorilation was completely abrogated in the nucleus of ATLD-2 cells that express a 
truncated Mre11 form. As expected, a phosphorilated Bid form was not detected in the cytosol. 
These data suggested that the ATM induced Bid phosphorilation is mediated by the MRN 
complex in response to DNA damage.  
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 To verify that Bid phosphorilation is dependent on ATM kinase we performed loss-of-function 
experiments by inhibiting ATM activity with the highly specific KU55933 compound 20, 21. 
MEFs were subjected to etoposide treatment either in the presence or absence of KU55933 ATM 
inhibitor and Bid activation was monitored by Western blotting with a S61-Bid phospho-specific 
antiserum. Results shown in Figure 2 D show that Bid phosporilation after etoposide treatment 
was completely abrogated in cells treated with the ATM inhibitor. Thus, as previously reported, 
the stimulation of Bid phosphorilation in response to DNA damaging agents is mainly a result of 
ATM activity. 
 
Recently accumulated evidence indicates that DNA breaks are sensed directly by the MRN 
complex, which recruits ATM after binding to DNA 3, 4. Our data suggest that Bid association 
with the Mre11 subunit of MRN complex is essential for the stimulation of Bid phosphorylation 
by ATM, consistent with the possibility that MRN induces conformation changes that facilitate 
ATM contacts with its substrates.  
 
Bid association with MRN complex is disrupted in Mre11 and Nbs1 deficient cells 
 
The results described above suggest that both Mre11 and Nbs1 MRN subunits are essential for 
Bid stimulation by ATM. However, ATM was reported to make multiple direct contacts with the 
MRN complex including independent associations with MR and Nbs1 subunit alone 3. To 
investigate whether Bid phosphorylation is contingent on Bid recruitment to an intact MRN 
complex Mre11 and Nbs1 deficient MEFs were treated with etoposide for 4 h and Bid 
association with Mre11 was determined by western blotting after immunoprecipitaions with 
either Mre11 or Bid specific antiserums. The results depicted in Figure 3A show that Mre11 was 
present in the immunoprecipitates from wild-type MEFs with Bid antiserum. In contrast, 
immunoprecipitates of whole-cell extracts from Mre11 and Nbs1 mutant MEFs revealed no 
detectable levels of Mre11. Parallel immunoprecipitation studies with Mre11 antibody yielded 
similar results (Figure 3B). Bid was readily detected in Mre11 immunoprecipitations of control 
and etoposide-treated wild-type MEFs, while none Bid association with Mre11 was found in 
Nbs1 and Mre11 negative MEFs. Collectively, the results of Figure 3A and B indicate that the 
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association of Bid with Mre11 is only possible only in the context of intact MRN complex. The 
detection of Bid in MRN precipitates from undamaged cells suggest that Bid-MRN is a pre-
existing complex also may explain the rapid Bid phosphorylation after genotoxic insults 12. 
These data are consistent with a recent study by Stacker et al. (2007) reporting lack of Bid 
phosporylation after DNA damage in Nbs1 mutant mice and suggest that ATM and Bid are 
independently recruited to the MRN complex 7. 
 
MRN complex remains intact after Bid knockdown 
 
The results described above predict a model whereby Bid is recruited to the MRN complex via 
its association with Mre11 immediately after DNA damage, which enables the ATM-mediated 
phosphorylation. However, it remains unclear whether Bid plays a role in MRN assembly at 
broken DNA molecules or it is only a downstream substrate of ATM. To gain insight into 
whether the disruption of Bid association with MRN complex might affect the assembly of MRN 
complex we analyzed the consequence of inhibiting Bid expression in MEFs by siRNA. 
Transfection of the Bid siRNA pool resulted in dramatic reduction in Bid levels (Figure 3C). 
Cells transfected with either a non-specific siRNA or Bid siRNAs were treated with etoposide 
for 4 h and MRN subunits and Bid were analyzed by western blotting following 
immunoprecipitation with a Mre11 antiserum. Figure 3D shows that Bid depletion had no effect 
on MRN complex formation. Nbs1, Rad50 and Mre11 were readily detected in Mre11 
immunoprecipitations from the control and Bid siRNA treated MEFs. As expected, Bid protein 
was present in Mre11 control immunoprecipitates, but was undetectable in Bid siRNA treated 
cells. Thus, RNAi-mediated depletion of Bid has no effect on MRN complex assembly 
confirming the autonomy of MRN.  
 
Loss of Bid inhibits intra-S phase checkpoint activation and prevents G2/M arrest 
 
The role of Bid in DNA damage response is a subject of intense investigations and remains a 
hotly debated issue 22, 23. Following the initial papers by Kamer et al. (2005) and Zinkel et al., 
(2005) describing Bid stimulation by ATM/ATR and its role in DNA damage response, 
Kufmann et al. (2007) in an independent study reported controversial data on Bid role in S phase 
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checkpoint activation, apoptosis activation and tumor development after double strand breaks 
induction 11, 12, 24. However, important differences between both experimental approaches have 
been noted. To address this issue and provide an alternative model for evaluating Bid function in 
DNA damage response we analyzed the effect of Bid depletion by siRNA on checkpoints 
activation and apoptosis induction after etoposide treatment in HeLa cells. We transfected HeLa 
cells with Bid siRNA and cell cycle profiling and apoptosis were analyzed by fluorescence-
activated cell sorting (FACS). Figure 4A shows that the control cells undergo a classic cell cycle 
arrest in response to DNA damage demonstrated by a temporary S phase delay (intra S phase 
checkpoint activation) and followed by G2/M arrest (G2/M checkpoint). In contrast, the 
inhibition of Bid expression resulted in a dramatic reduction of S phase cell accumulation 8 h 
after etoposide treatment and complete abrogation of G2/M checkpoint (Figure 4A and B). These 
results indicate that Bid depleted cells have an intra S phase checkpoint defect and are unable to 
trigger G2/M checkpoint arrest.  
 
In parallel we analyzed the effect of Bid inhibition on the rate of apoptosis following DNA 
damage induction as result of etoposide treatment. Following treatment with etoposide, an agent 
that induces DNA breaks and apoptosis trough inhibition of topoisomerase 2, approximately 12 
% and 20% cells were found to be Annexin V positive 8 h and 24 h, respectively, after etoposide 
application (Figure 4D). There was no significant difference in the cell death rate between the 
control and Bid depleted cells despite the fact that a small decrease in the number of apoptotic 
cell was observed in Bid siRNA cells (Figure 4D, 24 h timepoint). Thus, Bid knockdown in 
HeLas has no effect on apoptosis after DSB accumulation. We conclude that Bid is not involved 
in the apoptosis cascades after DSB induction, which is likely to be a result of etoposide and 
ionizing radiation (IR) inability to activate caspase 8 and produce a truncated apoptosis-
competent Bid isoform 11, 25 (Supplementary Figure 3). 
 
Loss of Bid association with the MRN complex leads mainly to abrogation of intra-S phase 
checkpoint activation. Several previous observations are consistent with the notion that Bid 
association with MRN is an essential part of DNA damage response 6, 11, 12, 26. ATM inability to 
phosphorylate Bid after double strand breaks induction in Nbs1 hypomorphic mice is especially 
revealing and consistent with our findings 7. Therefore, the phenotypic similarities between 
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Nbs1, Mre11 and Bid-negative cells are most likely linked to their failure to activate the intra-S-
phase checkpoint and indicate that Bid is major ATM-dependent checkpoint effector acting 
downstream of MRN complex.  
 
How might Bid exert an effect on S phase progression in response to DNA damage? The 
integration of Bid with the MRN DSB sensor, which provides a platform for the assembly of 
multiprotein complexes than might serve to link DNA damage sensors with the executioners of 
S-phase arrest. Interestingly, our proteomic approach identified three Bid-associated proteins, 
MCM5, casein kinase 2 (CK2) and Fen1 endonuclease that have been shown to function in DNA 
repair, apoptosis and DNA replication 17-19, 27-29. CK2 is a ubiquitous protein serine/threonine 
kinase that is involved in cell growth and proliferation, as well as suppression of apoptosis. 
Several studies have suggested that CK2 plays a role in cell cycle progression 30. CK2 facilitates 
S-phase progression and its ectopic expression leads to delays of S phase progression and 
inhibition of G2/M arrest after DNA damage. Moreover, CK2 was found to phosphorylate Bid 
under certain conditions and delay apoptosis 31. Fen1 interacts with PCNA and is critical for the 
efficient maturation of Okazaki fragments during replication 18, 28. Fen1 is also an essential 
component of DSB repair machinery and its deregulated expression affects the cell cycle and 
leads to growth defects and cancer development 18, 32, 33. Thus, Bid association with the MRN 
complex appears to be essential for the assembly of protein subcomplexes, which can directly 
affect the replication. 
 
To strengthen this conclusion, we performed a bioinformatic analysis of the proteins identified 
by our proteomics experiments. The interacting proteins were annotated with biological 
processes by the Ingenuity program (Figure 5). The cell cycle G2/M checkpoint regulation 
showed a highly significant enrichment (48% of annotated proteins were assigned to this 
category). Enrichment was also observed for p53 signaling cascades, followed by G1/S 
checkpoint regulation, death receptor signaling and hypoxia. These results support the 
conclusion that Bid association with Mre11 might lead to conformational changes and functional 
redirection of MRN complex associated proteins, as Fen1, MCM5 and CK2 that is manifested as 
an intra-S phase delay and abrogation of G2/M cell cycle arrest. 
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Methods 
Cells cultures, transfections and proteomics 
HeLa cells and mouse and human primary fibroblasts were propagated at 37 C in DMEM (Life 
Technologies) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 U/ml 
streptomycin. Cells were regularly passed to maintain exponential growth. Wild type, Ku70-/-, 
Mre11-/- and Nbs-/- primary murine embryo fibroblasts (MEFs) and human Mre11 deficient 
ATLD-2 primary cells were isolated and cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, 
100 U/ml of penicillin, and 100 µg/ml of streptomycin (Invitrogen) at 37°C in a humidified 
atmosphere with 5% CO2. Bid siRNA duplex has been published previously 34. The sequences of 
human Bid siRNAs are: Bid-A, 5′-GAA-GAC-AUC-AUC-CGG-AAU-AdTdT- 3′, Bid-B, 5’-
UAU_UCC-GGA-UGA-UGU-CUU-CdTdT-3’. Mouse Bid siRNAs have been purchased from 
Santa Cruz Biotech Transfections were performed by Oligofectamine (Life Technologies) or 
Metafectane (Biontex) and 50 nM siRNA as recommended by the manufacturers. Chemical 
crosslinking of Bid protein was carried out using the trifunctional crosslinkers biotin-sulfo-
SBED and Mts-Atf-Biotin (Pierce) as described previously 15.  
 
For affinity purification -2x107 HeLa cells were transfected with 10 µg recombinant Bid (R&D 
Systems) labeled with chemical crosslinkers using Chariot transfection reagent (Active Motif) 
according to the manufacturer recommendations. HeLa cells were transiently transfected with a 
recombinant highly purified Bid protein labeled with the biotin-linked photocrosslinkable 
reagents Sulfo-SBED on lysines and Mts-Atf on cysteins (Pierce). Bid protein contains three 
cysteine residues at the N-terminus and four lysine at the C-terminus which can be labeled by the 
chemical crosslinkers. Cells were treated with 20 nM etoposide 8 h after Bid transfection and 4 h 
later the photoactivatable crosslinkers were activated by UV light (365 nM, 15 min, 10 cm 
distance). All procedures were carried out on dark to prevent crosslinker activation until UV 
exposure. Nuclear extracts were prepared and Bid associated proteins were affinity purified by 
streptavidine magnetic beads (Dynal) blocked in buffer B (20 mM HEPES, pH7.5, 100 mM 
naCl, 30 mM KCl, 0.1 mM EDTA, 0.05 % Triton, 1 mg/ml BSA, 1 mM DTT) as described 15. 
Following affinity purification, beads were washed in buffer S (20 mM HEPES, pH7.5, 100 mM 
KCl, 1 mM DTT) and eluted by resuspendion in 2xSDS sample buffer and boiled for 5 min. 
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Proteins were resolved by SDS-PAGE and visualized by Colloidal Blue staining kit (Invitrogen). 
Bands were excised and analyzed by nanoflow LC tandem mass spectrometry (nanoLC-MS/MS). 
 
Protein analysis 
Immunoblot and immunoprecipitation assays were performed using polyclonal antibodies that 
specifically recognized the Ku70, Ku80, Mre11, Nbs1, Rad50, Bid, TBP (Santa Cruz Biotech) 
and GRB2 (BD Biosciences) as described previously 15. Briefly, immunoprecipitations studies 
were performed using 300 µg protein extracts and Bid or Mre11 antibodies. Samples were 
incubated for 4 h at 4 C and then mixed with Protein G Agarose beads (Dynal) overnight at 4 C. 
Samples were washed three times in buffer containing 20 mM HEPES, pH7.5, 200 mM NaCl, 
0.1 mM EDTA, 0.05 % Triton, 1 mM DTT and protease inhibitor cocktail (Roche), then washed 
once in the same buffer with 400 mM NaCl. 
 
Subcellular fractionation 
Approximately 2x10  cells were homogenized with 0.2 7 ml of ice-cold homogenization buffer 
(10mM Hepes, pH7.5, 10 mM KCl, 1.5 mM MgCl , 5 mM DTT, 0.5% NP40 and 0.1mM PMSF) 
and spun for 5 min at 3000 g. Nuclear extracts were prepared in buffer C (20 mM Hepes, 25% 
glycerol, 420 mM NaCl, 1.5 mM MgCl , 0.5 mM EDTA, 1 mM DTT, 01 mM PMSF, protease 
inhibitors tablets [Roche]).  
2
2
 
Whole-cell extracts were prepared in RIPA buffer. 
 
DNA damage induction 
Induction of DSBs in cultured cells was achieved by treatment with 20 µM etoposide ATM 
inhibition was carried out by treatment with the specific ATM inhibitor, KU55933 (Kudos 
Pharmaceuticals, as described 20, 21, 35.  
 
Cell death and cell cycle assays 
HeLa cells were treated with etoposide (20 µM). Apoptosis was measured by Annexin V-PE 
Apoptosis detection Kit (BD Pharmingen) as recommended by the manufacturer. Cell cycle 
profiling was carried out by PI exclusion and analyzed by ModFit software (Verify). 
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Bioinformatics analysis 
Bioinformatics analysis of the proteins identified by the proteomics approach was performed 
using Ingenuity program (Ingenuity Sysytems). 
 
References 
1. Bartek, J., Lukas, C. & Lukas, J. Checking on DNA damage in S phase. Nat Rev Mol Cell 
Biol 5, 792-804 (2004). 
2. Bartek, J. & Lukas, J. Mammalian G1- and S-phase checkpoints in response to DNA 
damage. Curr Opin Cell Biol 13, 738-747 (2001). 
3. Lee, J.H. & Paull, T.T. Direct activation of the ATM protein kinase by the 
Mre11/Rad50/Nbs1 complex. Science 304, 93-96 (2004). 
4. Lee, J.H. & Paull, T.T. ATM activation by DNA double-strand breaks through the 
Mre11-Rad50-Nbs1 complex. Science 308, 551-554 (2005). 
5. Carney, J.P. et al. The hMre11/hRad50 protein complex and Nijmegen breakage 
syndrome: linkage of double-strand break repair to the cellular DNA damage response. 
Cell 93, 477-486 (1998). 
6. Stewart, G.S. et al. The DNA double-strand break repair gene hMRE11 is mutated in 
individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587 (1999). 
7. Stracker, T.H., Morales, M., Couto, S.S., Hussein, H. & Petrini, J.H. The carboxy 
terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 
447, 218-221 (2007). 
8. Theunissen, J.W. et al. Checkpoint failure and chromosomal instability without 
lymphomagenesis in Mre11(ATLD1/ATLD1) mice. Mol Cell 12, 1511-1523 (2003). 
9. Williams, B.R. et al. A murine model of Nijmegen breakage syndrome. Curr Biol 12, 
648-653 (2002). 
10. Difilippantonio, S. et al. Role of Nbs1 in the activation of the Atm kinase revealed in 
humanized mouse models. Nat Cell Biol 7, 675-685 (2005). 
11. Kamer, I. et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 
122, 593-603 (2005). 
12. Zinkel, S.S. et al. A role for proapoptotic BID in the DNA-damage response. Cell 122, 
579-591 (2005). 
13. Hoetelmans, R. et al. Bcl-2 and Bax proteins are present in interphase nuclei of 
mammalian cells. Cell Death Differ 7, 384-392 (2000). 
14. Falck, J., Petrini, J.H., Williams, B.R., Lukas, J. & Bartek, J. The DNA damage-
dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 30, 290-
294 (2002). 
15. Mari, P.O. et al. Dynamic assembly of end-joining complexes requires interaction 
between Ku70/80 and XRCC4. Proc Natl Acad Sci U S A 103, 18597-18602 (2006). 
16. van Gent, D.C., Hoeijmakers, J.H. & Kanaar, R. Chromosomal stability and the DNA 
double-stranded break connection. Nat Rev Genet 2, 196-206 (2001). 
17. Loizou, J.I. et al. The protein kinase CK2 facilitates repair of chromosomal DNA single-
strand breaks. Cell 117, 17-28 (2004). 
 12
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
20
3.
1 
: P
os
te
d 
3 
O
ct
 2
00
7
18. Zheng, L., Dai, H., Qiu, J., Huang, Q. & Shen, B. Disruption of the FEN-1/PCNA 
interaction results in DNA replication defects, pulmonary hypoplasia, pancytopenia, and 
newborn lethality in mice. Mol Cell Biol 27, 3176-3186 (2007). 
19. Agarwal, M.K., Ruhul Amin, A.R. & Agarwal, M.L. DNA replication licensing factor 
minichromosome maintenance deficient 5 rescues p53-mediated growth arrest. Cancer 
Res 67, 116-121 (2007). 
20. Falck, J., Coates, J. & Jackson, S.P. Conserved modes of recruitment of ATM, ATR and 
DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005). 
21. Jazayeri, A. et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA 
double-strand breaks. Nature cell biology 8, 37-45 (2006). 
22. Kaufmann, T. et al. Response: does bid play a role in the DNA damage response? Cell 
130, 10-11 (2007). 
23. Zinkel, S.S., Hurov, K.E. & Gross, A. Bid plays a role in the DNA damage response. Cell 
130, 9-10; author reply 10-11 (2007). 
24. Kaufmann, T., Gugasyan, R., Gerondakis, S., Dixit, V.M. & Strasser, A. Loss of the 
BH3-only protein Bid does not rescue RelA-deficient embryos from TNF-R1-mediated 
fatal hepatocyte destruction. Cell Death Differ 14, 637-639 (2007). 
25. Clohessy, J.G., Zhuang, J., de Boer, J., Gil-Gomez, G. & Brady, H.J. Mcl-1 interacts with 
truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-
mediated apoptosis. J Biol Chem 281, 5750-5759 (2006). 
26. Difilippantonio, S. et al. Distinct domains in Nbs1 regulate irradiation-induced 
checkpoints and apoptosis. J Exp Med 204, 1003-1011 (2007). 
27. Homma, M.K. & Homma, Y. Regulatory role of CK2 during the progression of cell 
cycle. Mol Cell Biochem 274, 47-52 (2005). 
28. Chen, U., Chen, S., Saha, P. & Dutta, A. p21Cip1/Waf1 disrupts the recruitment of 
human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex. Proc 
Natl Acad Sci U S A 93, 11597-11602 (1996). 
29. Ryu, S., Holzschuh, J., Erhardt, S., Ettl, A.K. & Driever, W. Depletion of 
minichromosome maintenance protein 5 in the zebrafish retina causes cell-cycle defect 
and apoptosis. Proc Natl Acad Sci U S A 102, 18467-18472 (2005). 
30. Poole, A. et al. A global view of CK2 function and regulation. Mol Cell Biochem 274, 
163-170 (2005). 
31. Desagher, S. et al. Phosphorylation of bid by casein kinases I and II regulates its cleavage 
by caspase 8. Mol Cell 8, 601-611 (2001). 
32. Kucherlapati, M. et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid 
tumor progression. Proc Natl Acad Sci U S A 99, 9924-9929 (2002). 
33. Kim, J.M. et al. Identification of gastric cancer-related genes using a cDNA microarray 
containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer 
Res 11, 473-482 (2005). 
34. Broaddus, V.C. et al. Bid mediates apoptotic synergy between tumor necrosis factor-
related apoptosis-inducing ligand (TRAIL) and DNA damage. The Journal of biological 
chemistry 280, 12486-12493 (2005). 
35. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of 
the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64, 9152-9159 (2004). 
 
 
 13
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
20
3.
1 
: P
os
te
d 
3 
O
ct
 2
00
7
Acknowlegments 
We thank Atan Gross for the S61-Bid antiserum, Sandra Zinkel for providing the Bid expression 
vector, John Petrini for Mre11 deficient MEFs, Nikolaas Jaspers for ATLD human fibroblasts 
and Jeroen Essers for help with cell cycle profiling analysis. This work was supported by the 
AICR, the Dutch Cancer Foundation KWF, the Netherlands Scientific Organization and the 
European Union. 
 
 
Figure Legends 
 
Figure 1. Bid is associated in vivo with Mre11 and Ku70. 
(A) Schematic representation of the trifunctional crosslinkers used to label the recombinant 
Bid protein.  
(B)  Immunoblot analysis of Bid expression in nucleus of mock (control) and Bid-transfected 
HeLa cells. TBP levels were monitored as loading control and nuclear marker. 
(C)  Affinity purification of Bid-associated proteins from HeLa cells transfected with Bid 
labeled with photoactivatable crosslinkers (PHC) followed by treatment with 20 µM etoposide. 
Proteins were separated by SDS-PAGE and visualized by Colloidal Blue staining. 
Microsequenced bands are indicated. 
(D)  Bid was immunoprecipitated from control and etoposide-treated HeLa cells using an a-
Bid antibody, and the immunoprecipitates were analyzed for Mre11 and Rad50 by 
immunoblotting with polyclonal  αMre11 and α-Rad50 antibodies. 
(E)  Bid immunoprecipitates were analyzed for Ku70 and Ku80 with αKu70 and αKu80 
specific polyclonal antibodies. 
 
Figure 2. Bid phosphorylation by ATM after DNA damage is abrogated in Mre11 and Nbs1 
deficient MEFs. 
(A)  Wild-type (wt) and Mre11 and Nbs1 deficient MEFs were treated with etoposide for 4 h. 
Whole cell extracts were immunoblotted with anti-phospho BidS61/64 and αBid antibodies. 
GRB2 levels were monitored as a loading control. 
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(B)  Immonoblot analysis of phospho-Bid expression in wild-type (wt) and Ku70 defficient 
MEFs following etoposide treatment. Human primary fibroblasts (normal) and ATLD-2 cells 
were treated with etoposide and nuclear and cytosolic protein extracts were analyzed by western 
blotting using BidS61/64 and αBid antibodies. TBP and GRB2 were used as nuclear and 
cytosolic loading markers, respectively. 
(C)  Human primary fibroblasts (normal) and ATLD-2 cells were treated with etoposide and 
nuclear and cytosolic protein extracts were analyzed by western blotting using BidS61/64 and 
αBid antibodies. TBP and GRB2 were used as nuclear and cytosolic loading markers, 
respectively. 
(D)  Bid phosphorilation following DNA damage depends on ATM activity. MEFs were 
treated with ATM inhibitor for 2 h followed by etoposide treatment for 4 h. Effects on Bid 
phosphortylation were monitored by western blotting with BidS61/64 antiserum. αBid and 
αGRB2 were monitored as loading controls. 
 
Figure 3. Bid association with the MRN complex is abolished in Mre11 and Nbs1 deficient 
MEFs. 
(A)  Bid was immunoprecipitated from wild-type and Mre11 and Nbs1 deficient MEFs using 
an  α-Bid antibody, and the immunoprecipitates were analyzed for Mre11 by immunoblotting 
with polyclonal αMre11 antibody. 
 (B)  Mre11 immunoprecipitates from wild-type and Mre11 and Nbs1 deficient MEFs were 
analyzed for Bid by immunoblotting with polyclonal αBid antibody. 
(C)  Imunoblot analysis of MEFs transfected with either 200 nM non-specific (NS, control 
cells) or Bid siRNAs for 24 h. GRB2 was monitored as a loading control. 
(D)  Bid depletion does not affect MRN complex formation. Mre11 immunoprecipitates from 
etoposide-treated wild-type MEFs transfected with either non-specific (NS) or siRNA directed 
against Bid were analyzed for Rad50. Nbs1, Mre11 and Bid by immunoblotting with αRad50, 
αNbs1, αMre11, and αBid antibodies. 
 
Figure 4. Depletion of Bid by RNA interference prevents intra-S phase checkpoint activation 
following treatment with etoposide. 
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(A)  Cell-cycle analysis of a cells transfected with either non-specific (control) or directed 
against Bid siRNAs at 0, 8, and 24 h after etoposide treatment. 
(B) Percent of cells in G1, S, and G2/M phases were quantified. 
(C)  Imunoblot analysis of HeLa cells transfected with either 50 nM non-specific (NS, control 
cells) or Bid siRNAs for 48 h. GRB2 was monitored as a loading control. 
(D)  AnnexinV-FITC staining to monitor apoptosis in siRNA-transfected cells after etoposide 
treatment. Results presented in (B) and (D) are mean of tree independent experiments. Control – 
transfected with non-specific siRNA; siBid – transfected with Bid siRNA. 
 
Figure 5. Network modeling.  
(A) Modules identified by the Ingenuity program are presented using existing links. A solid 
line indicates direct interaction; a dot line indicates indirect interaction; a line without arrowhead 
indicates binding; an arrow from protein A to protein B indicates A affects B. Triangle indicates 
a kinase; diamond, enzyme; hexagon, translation regulator, trapezoid, transporter; horizontal 
oval, transcription regulator; vertical oval, transmembrane receptor. Filled nodes mark proteins 
identified by the proteomics screen. 
(B) Gene ontology analysis of interacting proteins. Candidate interacting proteins were 
assigned with specific pathways. Significance refers to –log(P value), which is obtained by 
Ingenuity program using right-tailed Fisher’s exact test. 
 
Supplementary Information 
 
Supplementary Figure 1. 
Schematic of the proteomics approach used to identify Bid-associated proteins in asynchronously 
growing HeLa cells. 
 
Supplementary Figure 2. 
(A)  Analysis of Bid protein after labeling with sulfo-SBED and Mts-Atf trifunctional 
crosslinkers. The shift of Bid molecular mass is indication for the crosslinkers incorporation. 
(B)  Affinity purification of Bid-associated proteins from HeLa cells transfected with Bid 
labeled with photoacticatable crosslinkers (PHC) followed by treatment with 20 nM etoposide. 
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Proteins were separated by SDS-PAGE and visualized by Colloidal Blue staining. Positions of 
protein size standards are shown. The same gel is shown in Figure 1C. 
 
Supplementary Figure 3. 
Immunoblot analysis of Bid expression following treatment of HeLa cells with TNFα (50 
ng/ml)/cycloxehimide (10 µM) and etoposide (20 nM). In contrast to TNFα/cycloheximide 
treated cells, Bid is not cleaved to tBid after etoposide exposure. 
 
Table 1. Summary of the proteins identified by LC-MS/MS analysis. 
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Table 1. Summary of the proteins identified by LC-MS/MS analysis. 
 
 
t # Mascot score NCBI ID Protein description MW % sequence coverage # uniqe peptides Alternative names
1 1663 gi|19924129 RAD50 homolog 154823 21.1 27 RAD50 
2 1284 gi|114639860 Meiotic recombination 11 homolog A 80964 25 19 MRE11 
3 625 gi|13606056 DNA dependent protein kinase catalytic subunit  470227 3.1 13 PRKDC 
4 595 gi|4557361 BH3 interacting domain death agonist 22152 39.5 7 BID 
5 513 gi23510448 Microchromosome maintenance complex component 5 82578 14.9 9 MCM5 
6 240 gi|4758356 Flap structure-specific endonuclease 1  42908 14.5 5 FEN1 
7 134 gi|4885377 Histone cluster 1, H1d  22336 9 2 HIST1H1D 
8 118 gi|114583184 Ku80 autoantigene (80 kDa) 81938 3.2 2 XRCC5 
9 81 gi|47678515 Ku70 autoantigene (70 kDa) 70747 4.4 2 XRCC6 
10 49 gi|599778 Casein kinase II alpha subunit  45242 1.8 1 CKII alpha 
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